Lake Street Initiates Coverage On Vivani Medical with Buy Rating, Announces Price Target of $4

Benzinga Newsdesk www.benzinga.com Neutral 58.1%

Neg 0% Neu 58.1% Pos 0%

Lake Street analyst Thomas Flaten initiates coverage on Vivani Medical (NASDAQ:VANI) with a Buy rating and announces Price Target of $4.